Asia-Pacific Ablation Technologies Market Analysis And Segment Forecasts To 2021

The Asia-Pacific Ablation Technologies market has been estimated at USD 660 Million in 2016 and is projected to reach USD 1184 Million by 2021, at a CAGR of 12.4% during the forecast period from 2016 to 2021. Ablation technologies are majorly employed for surgical procedures in cardiology disorders such as atrial fibrillation, arrhythmia, refractory hypertension and others; along with this, removal of cancerous and non-cancerous tumors is also important application of ablation devices.

Browse the report: http://www.orbisresearch.com/reports/index/asia-pacific-ablation-technologies-market-by-product-type-application-and-region-industry-analysis-size-share-growth-trends-and-forecasts-2016-2021

The market for Ablation Technologies is mainly driven due to increasing number of geriatric and obese population because geriatric and obese populations are more prone to chronic diseases, increasing use of minimally invasive surgery procedures, rising healthcare expenditure, emerging technologies for tumor management and increasing prevalence of cardiovascular diseases. But, the market growth can be hampered due to reuse and reprocessing of devices in developing countries, stringent government regulations and increased healthcare cost and containment measures.

Asia-Pacific market for Ablation Technologies is segmented based on Product, Type and Application. By Product, the market is further sub-segmented into Light/Laser ablators, Radiofrequency (RF) ablators, Electrical ablators, Ultrasound ablators, Microwave ablators, Cryoablation devices, and Hydrothermal ablators. By Type, the market is further sub-segmented into Light/Laser ablation, Radiofrequency (RF) ablation, Electrical ablation, Ultrasound ablation, Microwave ablation, Cryoablation, and Hydrothermal ablation. By Application, the market is further sub-segmented into Cardiovascular Disease, Cancer, Ophthalmologic, Gynecologic, Pain Management, Urologic, Orthopedic, Cosmetic Surgery and Other treatments. Radiofrequency-based ablation technology segment is expected to lead the Asia-Pacific ablation technologies market based on Type. Based on Application, large market share is attributed to cardiovascular diseases treatment segment.

Request a sample of the report: http://www.orbisresearch.com/contacts/request-sample/346085

Geographically, Asia-Pacific market for Ablation Technologies is segmented into China, India, Japan, South Korea and Australia. The Ablation Technologies market in the Asia-Pacific region is projected to grow at the highest CAGR, which is greatly due to increasing popularity of minimally invasive surgeries in the region, government support to increase population access for elective surgeries, increasing investment by global players in the region.

Biosense Webster, Inc., St. Jude Medical, Inc., Boston Scientific Corporation, AngioDynamics, Inc., AtriCure, Inc., Smith & Nephew plc, Galil Medical Inc., CONMED Corporation, Olympus Corporation, Covidien PLC, Medtronic, Inc., BSD Medical Corporation, are the major players of Asia-Pacific Ablation Technologies market.

Major Points From The Table Of Contents:

Introduction

Research Methodology

Overview

Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

Market Segmentation

Geographical Analysis

Strategic Analysis

Market Leaders’ Analysis

Competitive Landscape

Market Outlook and Investment Opportunities

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Information:

Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Email: sales@orbisresearch.com